VIAPIANA, Ombretta
 Distribuzione geografica
Continente #
EU - Europa 14.016
NA - Nord America 13.229
AS - Asia 9.676
SA - Sud America 1.313
AF - Africa 311
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 11
Totale 38.579
Nazione #
US - Stati Uniti d'America 12.964
RU - Federazione Russa 5.144
SG - Singapore 3.895
GB - Regno Unito 3.019
CN - Cina 2.880
IT - Italia 1.847
BR - Brasile 1.030
DE - Germania 911
VN - Vietnam 866
HK - Hong Kong 801
SE - Svezia 717
FR - Francia 677
IE - Irlanda 604
FI - Finlandia 422
KR - Corea 288
IN - India 207
JP - Giappone 156
UA - Ucraina 156
CA - Canada 139
TR - Turchia 131
AR - Argentina 105
PL - Polonia 93
BD - Bangladesh 92
NL - Olanda 88
MX - Messico 86
NG - Nigeria 75
ES - Italia 70
ID - Indonesia 66
ZA - Sudafrica 65
IQ - Iraq 57
AT - Austria 54
BE - Belgio 48
EC - Ecuador 45
BJ - Benin 36
VE - Venezuela 35
UZ - Uzbekistan 31
CO - Colombia 29
PK - Pakistan 29
CL - Cile 25
RO - Romania 24
EG - Egitto 21
MA - Marocco 21
TG - Togo 21
IR - Iran 19
LT - Lituania 19
SA - Arabia Saudita 19
CH - Svizzera 18
KE - Kenya 18
PE - Perù 18
AU - Australia 17
IL - Israele 14
AE - Emirati Arabi Uniti 13
AZ - Azerbaigian 12
MY - Malesia 12
PH - Filippine 12
PY - Paraguay 11
CR - Costa Rica 10
DZ - Algeria 10
AL - Albania 9
CZ - Repubblica Ceca 9
GR - Grecia 9
HR - Croazia 9
NP - Nepal 9
BG - Bulgaria 8
DK - Danimarca 8
JO - Giordania 8
TN - Tunisia 8
BO - Bolivia 7
ET - Etiopia 7
LB - Libano 7
PT - Portogallo 7
SN - Senegal 7
HU - Ungheria 6
QA - Qatar 6
UY - Uruguay 6
AM - Armenia 5
DO - Repubblica Dominicana 5
JM - Giamaica 5
KG - Kirghizistan 5
NZ - Nuova Zelanda 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
TH - Thailandia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CI - Costa d'Avorio 4
EE - Estonia 4
EU - Europa 4
GE - Georgia 4
LV - Lettonia 4
NO - Norvegia 4
RS - Serbia 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
BH - Bahrain 3
HN - Honduras 3
KW - Kuwait 3
KZ - Kazakistan 3
MK - Macedonia 3
PS - Palestinian Territory 3
SI - Slovenia 3
Totale 38.523
Città #
Southend 2.632
Singapore 2.079
Moscow 1.754
Ashburn 1.624
Chandler 1.335
San Jose 1.302
Dallas 1.231
Jacksonville 883
Hong Kong 788
Dublin 600
Verona 484
Beijing 482
Ann Arbor 475
Woodbridge 465
The Dalles 384
New York 308
Houston 304
Los Angeles 274
Ho Chi Minh City 270
Lawrence 234
Princeton 234
Wilmington 232
Jinan 224
Redmond 194
Bologna 190
Hanoi 184
Nanjing 173
Shenyang 173
Munich 143
Tokyo 138
Helsinki 136
Buffalo 122
Milan 112
Hebei 104
São Paulo 104
Tianjin 104
Redondo Beach 102
Santa Clara 85
Sindelfingen 85
Warsaw 80
London 76
Changsha 75
Orem 73
Zhengzhou 73
Abuja 72
Ningbo 68
Haikou 67
Columbus 65
Denver 59
Nanchang 58
Taizhou 58
Guangzhou 55
Hangzhou 54
Redwood City 54
Montreal 52
Brooklyn 51
Falkenstein 50
Seattle 50
Jiaxing 49
Rome 49
San Francisco 47
Brussels 45
Turku 45
Taiyuan 44
Chicago 43
Da Nang 43
Phoenix 43
Johannesburg 39
Toronto 39
Atlanta 38
Hyderabad 38
Boardman 36
Cotonou 36
Poplar 36
Washington 36
Manchester 35
Norwalk 35
Chennai 34
Council Bluffs 34
Frankfurt am Main 34
Mexico City 34
Stockholm 33
Vienna 33
Boston 32
Rio de Janeiro 32
Fuzhou 30
Brasília 29
Tashkent 29
Amsterdam 27
Düsseldorf 27
Fairfield 27
Haiphong 27
Jakarta 26
Lanzhou 26
Dong Ket 25
Falls Church 23
Dearborn 22
Paris 22
Torino 22
Baghdad 21
Totale 23.362
Nome #
Efficacia dei bisfosfonati nella terapia della spondilite anchilosante: confronto con infliximab 691
Teriparatide and denosumab combination therapy and skeletal metabolism 340
Artrite Reumatoide e Metabolismo Minerale 268
[The long term correction of vitamin D deficiency: comparison between different treatments with vitamin D in clinical practice.]. 265
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 259
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 251
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 251
Anti-CCP antibodies and bone 239
La correzione dell’ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica. 227
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 224
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 221
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 218
Bone metabolism in patients with anorexia nervosa and amenorrhoea 218
[Risk factors for hip fracture in elderly persons]. 214
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 212
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 210
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 209
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 209
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 206
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' 206
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 205
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 205
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 204
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 202
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 201
Bone involvement and osteoporosis in mastocytosis. 200
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 200
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 197
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 196
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 194
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 191
Prevalence and incidence of rheumatoid arthritis in Italy. 187
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 187
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 187
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 186
Could γ\δ T-cells explain zoledronic acid adverse events? 186
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 186
Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease 184
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 184
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 183
[Pathophysiology of osteoarthritis: perspectives] 182
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 181
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 179
Allergy and the bone: unexpected relationships 176
An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis 176
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 175
Guidelines for the diagnosis, prevention and management of osteoporosis 175
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 175
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 174
Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease 173
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 171
Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study 170
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 169
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction 169
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 166
DXA bone mineral density in males: retrospective study in real life. 166
Calcio e derivati della vitamina D, terapia sostitutiva, calcitonina, fluoruri, bisfosfonati 166
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 166
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 165
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 165
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 164
Bone Disease in Mastocytosis 164
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 164
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 163
Are aortic coarctation and rheumatoid arthritis different models of aortic stiffness? Data from an echocardiographic study 162
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 162
Is it possible to use the identification of neutrophil gelatinase- associated lipocalin (NGAL) in the evaluation of bisphosphonates nephrotoxicity? [E' possibile utilizzare la determinazione della lipocalina associata alla gelatinasi dei neutrofili (NGAL) nella valutazione della nefrotossicità da bisfosfonati?] 161
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome 160
Effects of denosumab on peripheral lymphocyte subpopulations 160
Artropatie degenerative 159
Sclerostin and DKK1 in primary hyperparathyroidism. 159
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 158
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 157
Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis 157
Effects of antiangiogenetic drugs on microcirculation and macrocirculation in patients with advanced-stage renal cancer 157
Prevalence of osteoporosis in patients affected by mastocytosis 156
Safety issues and adverse reactions with osteoporosis management 156
Relationship between common carotid distensibility/aortic stiffness and cardiac left ventricular morphology and function in a group of patients affected by chronic rheumatic diseases: an observational study 156
Association between environmental air pollution and rheumatoid arthritis flares 156
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 155
The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 154
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 154
Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset 154
Correction to: The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 153
Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women. 152
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 151
Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study 151
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 151
Improvements in the management of rheumatic patients from vertebral imagee obtained through dual-energy X-ray absorptiometry. 150
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 150
Osteopetrosi 149
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 149
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 149
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 149
Malnutrition and sarcopenia in a large cohort of patients with systemic sclerosis 148
Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros 146
The Association between Weight Gain/Restoration and Bone Mineral Density in Adolescents with Anorexia Nervosa: A Systematic Review 146
Invecchiamento dell'apparato scheletrico 145
Relationship Between Increased Fecal Calprotectin Levels and Interstitial Lung Disease in Systemic Sclerosis 145
Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF-α Receptor-Associated Periodic Syndrome (TRAPS): A Series of 80 Cases from the AIDA Network 145
Totale 18.619
Categoria #
all - tutte 126.398
article - articoli 121.107
book - libri 0
conference - conferenze 646
curatela - curatele 0
other - altro 1.376
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.269
Totale 252.796


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021318 0 0 0 0 0 0 0 0 0 15 202 101
2021/20221.908 127 520 29 110 88 55 59 107 145 48 143 477
2022/20234.026 282 380 382 709 332 966 51 224 461 59 129 51
2023/20242.170 111 163 193 264 238 344 103 171 28 92 318 145
2024/20255.346 286 344 259 800 248 166 220 210 789 419 529 1.076
2025/202616.853 1.202 888 1.302 3.039 4.525 1.189 1.646 977 1.267 818 0 0
Totale 39.105